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Humanized monoclonal antibodies (mAb) targeting
tumor antigens have paved the way to complementary
strategies in the treatment of cancer by harnessing the
immune system towards a more specific response against
tumors. Such mAb can mobilize natural killer (NK) cells
function by mediating antibody-dependent cell cytotoxi-
city (ADCC). ADCC can be enhanced through Fc-region
modification, but high affinity-Fc mAb have been asso-
ciated with NK cell depletion. Here, we have quantified
in vitro the improvement of NK cell-mediated ADCC
brought by a humanized mAb targeting CD33 (HuM195)
engineered in its Fc domain (DLE mutation). We used
human NK cells in cytotoxicity assays against murine
EL4 tumor cells transfected with human CD33 and
pre-coated with the DLE HuM195 anti-CD33 antibody.
In parallel, human K562 cells were used as targets in
comparative assays to quantify kinetics of direct tumor
recognition. A single-cell assay combining high through-
put microscopy and immuno-printing of thousands of
NK-target cell interactions allowed us to observe effector-
mediated apoptosis and to measure cytokine secretion. We
demonstrated that the DLE HuM195 anti-CD33 antibody
increased NK cell-mediated ADCC up to 3 times compared
with the non-mutated HuM195 anti-CD33 in a bulk cyto-
toxicity assay. In the single-cell assay, we confirmed that the
DLE-engineered HuM195 potentiated the cytotoxicity of
NK cells against CD33-expressing target cells by endowing
more NK cells with killing function as compared to
wild type HuM195 (19% with DLE HuM195 vs 1% with
HuM195), by increasing their serial killing ability (5-19%
involved in serial killing with DLE HuM195 vs 0-1% without
antibody) and by stimulating their IFN-g secretion. Dynamic
timelapse monitoring showed that ADCC speeded up
the kinetics of target conjugation, which was further
increased by DLE HuM195. Secondly, DLE HuM195 neces-
sitated fewer contacts to induce target apoptosis but also
increased activation-induced cell death of NK cells. How-
ever, this increased AICD was independent of serial killing.
Antibody-based therapies targeting tumor antigens will
benefit from better understanding of cell-mediated tumor
elimination. Single-cell analysis shows that Fc-modified
mAb can significantly enhance NK cell killing of targets
through improved recruitment of NK cells, conjugation
kinetics, and serial killing. Enhanced target killing is also
associated with increased AICD of NK cells, but the balance
of effect favors the Fc modification for enhanced efficacy.
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